Work

Venetoclax Combined with Bortezomib and Dexamethasone for Patients with Relapsed/Refractory Multiple Myeloma

Year: 2016

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v128.22.975.975

Authors: Philippe Moreau, Asher A. Chanan-Khan, Andrew W. Roberts, Amit B. Agarwal, Thierry Facon, Shaji Kumar, Cyrille Touzeau, Jaclyn Cordero, Jeremy Ross, Wijith Munasinghe, Jia Jia, Ahmed H. Salem, Joel Leverson, Paulo Maciag, Maria Verdugo, Simon J. Harrison

Institutions: Centre Hospitalier Universitaire de Nantes, Mayo Clinic, Mayo Clinic in Florida, The Royal Melbourne Hospital, Walter and Eliza Hall Institute of Medical Research, University of Arizona, Centre Hospitalier Universitaire de Lille, Hôpital Claude Huriez, AbbVie (United States), Peter MacCallum Cancer Centre

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2605778696

FWCI: 5

Cites:

Cited by: 24

Related to: 10